(Click on the pictures for larger version.) |
|
Ulkar Kimya (subsidiary of Ulkar Holding) has two different Research and Development (R&D) laboratories. These laboratories are established to develop generic active pharmaceutical ingredients (API) and operate with 15 academic personnel. R&D activities are; patent research, process development, analytical method development, validations and their documentation. Process developments are designed in laboratory scale and implemented to the production, pilot scale and commercial scale respectively. Drug Masters File (DMF) preparations are completed and updated by technical documentation department according to appropriate pharmacopeias. |
info@ulkarkimya.com.tr
